The role of platelet-derived endothelial cell growth factor/thymidine phosphorylase in tumor behavior

Nucleosides, Nucleotides and Nucleic Acids

Volumn 27, Issue 6-7, 2008, Pages 681-691

  Bijnsdorp, I V ^a   De Bruin, M ^a   Laan, A C ^a   Fukushima, M ^b   Peters, G J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b TAIHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Angiogenesis; Fluoropyrimidines; Migration; Thymidine phosphorylase

Indexed keywords

DEOXYRIBOSE; DOXYRIBOSE 1 PHOSPHATE; ENZYME INHIBITOR; INTERLEUKIN 10; PHOSPHATE; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; REACTIVE OXYGEN METABOLITE; THYMIDINE; THYMIDINE PHOSPHORYLASE; THYMIDINE PHOSPHORYLASE INHIBITOR; THYMINE; TUMOR NECROSIS FACTOR;

ANGIOGENESIS; CATALYSIS; CELL ENERGY; CELL METABOLISM; CELL MIGRATION; CHEMICAL REACTION; CONFERENCE PAPER; ENERGY METABOLISM; ENZYME ACTIVITY; ENZYME REGULATION; HUMAN; METASTASIS; NONHUMAN; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; STROMA; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL; TUMOR GROWTH; UPREGULATION;

CELL MOVEMENT; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS; SIGNAL TRANSDUCTION; THYMIDINE PHOSPHORYLASE;

EID: 46749126538     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257770802143988     Document Type: Conference Paper

References (44)

1. Takebayashi, Y.; Akiyama, S.; Akiba, S.; Yamada, K.; Miyadera, K.; et al. Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma. J. Natl. Cancer Inst. 1996, 88, 1110-1117.
2. Liekens, S.; Bronckaers, A.; Pérez-Pérez, MJ.; Balzarini, J. Targeting platelet-derived endothelial cell growth factor/thymidine phosphorylase for cancer therapy. Biochem. Pharmacol. 2007, 74, 1555-1567.
3. De Bruin, M..; Temmink, O.H.; Hoekman, K.; Pinedo, H.M.; Peters, G.J. Role of platelet derived endothelial cell growth factor/thymidine phosophorylase in health and disease. Cancer Ther. 2006 4, 99-124.
4. Asai, K..; Hirano, T.; Matsukawa, K.; Kusada, J.; Takeuchi, M.; et al. High concentrations of immunoreactive gliostatin/platelet-derived endothelial cell growth factor in synovial fluid and serum of rheumatoid arthritis. Clin. Chim. Acta 1993, 218, 1-4.
5. de Bruin, M.; van Capel, T.; Van der Born, K.; Kruyt, FA.; Fukushima, M.; et al. Role of platelet-derived endothelial cell growth factor/thymidine phosphorylase in fluoropyrimidine sensitivity. Br. J. Cancer 2003, 88, 957-964.
6. Temmink, O.H.; de Bruin, M.; Turksma, A.W.; Cricca,S.; Laan, A.C; Peters, G.J. Activity and substrate specificity of pyrimidine phosphorylases and their role in fluoropyrimidine sensitivity in colon cancer cell lines. Int. J. Biochem. Cell. Biol. 2007, 39, 565-575.
7. Kamba, T.; McDonald, D.M. Mechanisms of adverse effects of anti-VEGF therapy for cancer. Br. J. Cancer 2007, 96, 1788-1795.
8. Hotchkiss, K.A.; Ashton, A.W.; Klein, R.S.; Lenzi, M.L.; Zhu, G.H.; Schwartz, E.L. Mechanisms by which tumor cells and monocytes expressing the angiogenic factor thymidine phosphorylase mediate human endothelial cell migration. Cancer Res. 2003, 63, 527-533.
9. Hotchkiss, K.A.; Ashton, A.W.; Schwartz, E.L. Thymidine phosphorylase and 2-deoxyribose stimulate human endothelial cell migration by specific activation of the integrins alpha 5 beta 1 and alpha V beta 3. J Biol Chem. 2003, 278, 19272-19279.
10. Seeliger, H.; Guba, M.; Koehl, G.E.; Doenecke, A.; Steinbaue,r M.; et al. Blockage of 2-deoxy-Dribose-induced angiogenesis with rapamycin counteracts a thymidine phosphorylase-based escape mechanism available for colon cancer under 5-fluorouracil therapy. Clin. Cancer Res. 2004, 10, 1843-1852.
11. Malik, R.K.; Parsons, J.T. Integrin-dependent activation of the p70 ribosomal S6 kinase signaling pathway. J. Biol. Chem. 1996, 271, 29785-29791.
12. Matsukawa, K.; Moriyama, A.; Kawai, Y.; Asai, K.; Kato, T Tissue distribution of human gliostatin/platelet-derived endothelial cell growth factor (PD-ECGF) and its drug-induced expression. Biochim. Biophys. Acta 1996, 1314, 71-82.
13. Uchimiya, H.; Furukawa, T.; Okamoto, M.; Nakajima, Y.; Matsushita, S.; et al. Suppression of thymidine phosphorylase-mediated angiogenesis and tumor growth by 2-deoxy-L-ribose. Cancer Res. 2002, 62, 2834-2839.
14. de Bruin, M.; Smid, K.; Laan, A.C.; Noordhuis, P.; Fukushima, M.; et al. Rapid disappearance of deoxyribose-1-phosphate in platelet derived endothelial cell growth factor/thymidine phosphorylase overexpressing cells. Biochem. Biophys. Res. Commun. 2003, 301, 675-679.
15. Grierson, J.R.; Brockenbrough, J.S.; Rasey, J.S.; Wiens, L.W.; Schwartz, J.L.; et al. Evaluation of 5′-deoxy-5′-[F-18]fluorothymidine as a tracer of intracellular thymidine phosphorylase activity. Nucl Med Biol. 2007, 34, 471-478.
16. Brown, N.S.; Streeter, E.H.; Jones, A.; Harris, A.L.; Bicknell, R. Cooperative stimulation of vascular endothelial growth factor expression by hypoxia and reactive oxygen species: the effect of targeting vascular endothelial growth factor and oxidative stress in an orthotopic xenograft model of bladder carcinoma.Br. J. Cancer 2005, 92, 1696-1701.
17. DeForge, L.E.; Preston, A.M.; Takeuchi, E.; Kenney, J.; Boxer, L.A.; Remick, D.G. Regulation of interleukin 8 gene expression by oxidant stress. J. Biol. Chem. 1993, 268, 25568-25576.
18. Wenk, J.; Brenneisen, P.; Wlaschek, M.; Poswig, A.; Briviba, K.; et al. Stable overexpression of manganese superoxide dismutase in mitochondria identifies hydrogen peroxide as a major oxidant in the AP-1-mediated induction of matrix-degrading metalloprotease-1. J. Biol. Chem. 1999, 274, 25869-25876.
19. Kuroki, M.; Voest, E.E.; Amano, S.; Beerepoot, L.V.; Takashima, S.; et al. Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. J. Clin. Invest. 1996, 98, 1667-1675.
20. Li, W.; Tanaka, K.; Morioka, K.; Uesaka, T.; Yamada, N.; et al. Thymidine phosphorylase gene transfer inhibits vascular smooth muscle cell proliferation by upregulating heme oxygenase-1 and p27KIP1. Arterioscler. Thromb. Vasc. Biol. 2005, 25, 1370-1375.
21. Torisu-Itakura, H.; Furue, M.; Kuwano, M.; Ono, M. Co-expression of thymidine phosphorylase and heme oxygenase-1 in macrophages in human malignant vertical growth melanomas Jpn. J. Cancer Res. 2000, 91, 906-910.
22. Oates, P.S.; West, A.R. Heme in intestinal epithelial cell turnover, differentiation, detoxification, inflammation, carcinogenesis, absorption and motility. World J. Gastroenterol. 2006, 12, 4281-4295.
23. Stocker, R.; Yamamoto, Y.; McDonagh, A.F.; Glazer, A.N.; Ames, B.N. Bilirubin is an antioxidant of possible physiological importance. Science 1987, 235, 1043-1046.
24. Kitazono, M.; Takebayashi, Y.; Ishitsuka, K.; Takao, S.; Tani, A.; et al. Prevention of hypoxia-induced apoptosis by the angiogenic factor thymidine phosphorylase. Biochem. Biophys. Res. Commun. 1998, 253, 797-803.
25. Matsushita, S.; Nitanda, T.; Furukawa, T.; Sumizawa, T.; Tani, A.; et al. The effect of a thymidine phosphorylase inhibitor on angiogenesis and apoptosis in tumors. Cancer Res. 1999, 59, 1911-1916.
26. Osaki, M.; Sakatani, T.; Okamoto, E.; Goto, E.; Adachi, H.; Ito, H. Thymidine phosphorylase expression results in a decrease in apoptosis and increase in intratumoral microvessel density in human gastric carcinomas Virchows Arch. 2000, 437, 31-36.
27. Hata, K.; Fujiwaki, R.; Nakayama, K.; Maede, Y.; Fukumoto, M.; Miyazaki,K. Expression of thymidine phosphorylase and vascular endothelial growth factor in epithelial ovarian cancer: correlation with angiogenesis and progression of the tumor. Anticancer Res. 2000, 20, 3941-3949.
28. Fang, J.; Akaike, T.; Maeda, H. Antiapoptotic role of heme oxygenase (HO) and the potential of HO as a target in anticancer treatment. Apoptosis 2004, 9, 27-35.
29. Griffiths, L.; Dachs, GU.; Bicknell, R.; et al. The influence of oxygen tension and pH on the expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast tumor cells grown in vitro and in vivo. Cancer Res. 1997, 15, 570-572.
30. Rofstad, E.K.; Halsør, E.F.Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts.Cancer Res. 2000, 60, 4932-4938.
31. Ioachim, E.; Michael, M.; Salmas, M.; Michael, M.M.; Stavropoulos, N.E.; Malamou-Mitsi, V. Hypoxia-inducible factors HIF-1alpha and HIF-2alpha expression in bladder cancer and their associations with other angiogenesis-related proteins. Urol. Int. 2006, 77, 255-263.
32. Currie, M.J.; Gunningham, S.P.; Han, C.; et al. Angiopoietin-1 is inversely related to thymidine phosphorylase expression in human breast cancer, indicating a role in vascular remodeling. Clin. Cancer. Res. 2001, 7, 918-927.
33. Pyo, H.; Kim, Y.B.; Cho, N.H.; Suh, C.O.; Park, T.K.; et al. Coexpression of cyclooxygenase-2 and thymidine phosphorylase as a prognostic indicator in patients with FIGO stage IIB squamous cell carcinoma of uterine cervix treated with radiotherapy and concurrent chemotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2005, 62, 725-732.
34. Yamashita, H.; Osaki, M.; Ardyanto, T.D.; Osaki, M.; Yoshida,H.; Ito, H. Cyclooxygenase-2 in human malignant fibrous histiocytoma: correlations with intratumoral microvessel density, expression of vascular endothelial growth factor and thymidine phosphorylase. Int. J. Mol. Med. 2004, 14, 565-570.
35. Fujiwaki, R.; Iida, K.; Kanasaki, H.; Ozaki, T.; Hata, K.; Miyazaki ,K. Cyclooxygenase-2 expression in endometrial cancer: correlation with microvessel count and expression of vascular endothelial growth factor and thymidine phosphorylase. Hum. Pathol. 2002, 33, 213-219.
36. Harizi, H.; Gualde, N. Pivotal role of PGE2 and IL-10 in the cross-regulation of dendritic cell-derived inflammatory mediators. Cell. Mol. Immunol. 2006, 3, 271-277.
37. Jeung, H.C.; Che, X.F.; Haraguchi, M.; Zhao, H.Y.; Furukawa, T.; Gotanda, T.; et al. Protection against DNA damage-induced apoptosis by the angiogenic factor thymidine phosphorylase. FEBS Lett. 2006, 580, 1294-1302.
38. Balkwill, F.; Charles, K.A.; Mantovani, A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease.Cancer Cell 2005, 7(3), 211-217.
39. Hagemann, T.; Wilson, J.; Burke, F.; Kulbe, H.; Li, N.F.; et al. Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype. J. Immunol. 2006, 176, 5023-5032.
40. Pollard, J.W. Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer 2004, 4, 71-78.
41. Takahashi, Y.; Bucana, C.D.; Liu, W.; Yoneda, J.; Kitadai, Y.; et al. Platelet-derived endothelial cell growth factor in human colon cancer angiogenesis: role of infiltrating cells. J. Natl. Cancer. Inst. 1996, 88, 1146-1151.
42. Yao, Y.; Kubota, T.; Sato, K.; Kitai, R. Macrophage infiltration- associated thymidine phosphorylase expression correlates with increased microvessel density and poor prognosis in astrocytic tumors. Clin. Cancer Res. 2001, 7, 4021-4026.
43. Zhu, G.H.; Schwartz, E.L. Expression of the angiogenic factor thymidine phosphorylase in THP-1 monocytes: induction by autocrine tumor necrosis factor-alpha and inhibition by aspirin. Mol. Pharmacol. 2003, 64, 1251-1258.
44. Saito, S.; Tsuno, N.; Nagawa, H.; Sunami, E.; Zhengxi, J.; et al. Expression of platelet-derived endothelial cell growth factor correlates with good prognosis in patients with colorectal carcinoma. Cancer 2000, 88, 42-49.